Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-06-26

Clinical Trial Update: Feasibility Study to Evaluate the Safety of Topically Applied Revera in Subjects With Venous Leg Ulcers [Phase 1]

View source ↗

Summary

Phase 1 feasibility study assessing the safety of a topical product called Revera in adults with venous leg ulcers; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Revera

Snippet

Sponsor: Revalesio Corporation | Conditions: Venous Stasis Ulcers | Phase 1 | Status: COMPLETED